Company intelligence / Profile preview

Centivax

South San Francisco, California, United Statescentivax.com ↗

Ownership: Private
Employees: ~20
Development stage: Preclinical

Overview

Centivax has demonstrated proof-of-concept for its universal vaccine platform with significant non-dilutive funding from major organizations. Its lead program—a universal flu vaccine—is in GMP production and expected to enter clinical trials within a year. The company also develops broad-spectrum antivenoms and antibody-based therapies targeting high-priority infectious diseases. All programs are currently in preclinical stages but have shown promising results in animal models such as ferrets and pigs for influenza prevention

Therapeutic areas: OtherInfectious Diseases
Modalities: Antibodies (including monoclonal antibodies)Prophylactic vaccinesBlood components
Industry: Biotech

Drug pipeline

4 assets

Universal Snake Antivenom

Preclinical

3 more assets in the full pipeline.

Request access →

Partnerships

Emery Pharma—collaboration on accelerating universal vaccine development through advanced testing capabilitiesBill & Melinda Gates FoundationDODArmyNavyNIH

Beyond the preview

Go deeper on Centivax.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centivax.

Explore the full profile